Table 1 Clinical features of bladder cancer patients in the present study
Clinical parameters | Bilharzial bladder cancer subgroup | Non- bilharzial bladder cancer subgroup | Total | |
|---|---|---|---|---|
|  |  | n = 22(%) | n = 44 (%) |  |
Gender | Male | 18 (27.3) | 30 (45.5) | 48 (72.7) |
| Â | Female | 4 (6.1) | 14 (21.1) | 18 (27.3) |
Age (yrs) | ≤ 60 | 7 (10.6) | 20 (30.3) | 27 (40.9) |
| Â | >60 | 15 (22.7) | 24 (36.4) | 39 (59.1) |
Tumor size | ≤ 5 cm | 4 (6.1) | 24 (36.4) | 28 (42.4) |
| Â | >5Â cm | 18 (27.3) | 20 (30.2) | 38 (57.6) |
Tumor type | TCC | 13 (19.7) | 32 (48.5) | 45 (68) |
| Â | SCC | 9 (13.6) | 12 (18.2) | 21 (32) |
Tumor grade | 1/2 | 16 (24.5) | 27 (40.4) | 43 (65) |
| Â | 3/4 | 5 (7.7) | 15 (22.9) | 20 (30) |
| Â | Missing | 1 (1.5) | 2 (3.0) | 3 (5) |
Lymph-node | present | 2 (3) | 2 (3) | 4 (6) |
| Â | Absent | 20 (30.4) | 42 (63.6) | 62 (94) |
Prostatic invasion | Â | Â | Â | Â |
| Â | Present | 5 (7.6) | 5(7.6) | 10 (15.2) |
| Â | Absent | 17 (25.8) | 39 (59) | 56 (84.8) |